Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vacc... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895745) titled 'Volumetric Adaptive SBRT Versus Conventional Accelerated Radiation Therapy for Early-Stage ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895446) titled 'Effects of AI-Generated Resistance Training on Neuromuscular Performance in Sedentary Men' ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Tucatinib continuation protocol: an open label study for participants from tucatinib clinical stud... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A PHASE III, MULTICENTER, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-0863... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wi... Read More